Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 70
years old
The phase for this study is not defined.
Show me locations

The purpose

This trial is aimed at evaluating the safety and efficacy of IDH1R132H-DC vaccine in glioma with IDH1R132H mutation.

Provided treatments

  • Biological: dendritic cells
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02771301. The sponsor of the trial is Hebei Yanda Hospital and it is looking for 30 volunteers for the current phase.
Official trial title:
Safety and Efficacy of IDH1R132H-DC Vaccine in Gliomas